This company is no longer active
BELLUS Health Crecimiento futuro
Future controles de criterios 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BELLUS Health.
Información clave
46.1%
Tasa de crecimiento de los beneficios
41.4%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Biotechs | 36.5% |
| Tasa de crecimiento de los ingresos | 69.0% |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 16 Jun 2023 |
Actualizaciones recientes sobre el crecimiento futuro
No hay actualizaciones
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2025 | 40 | -147 | -110 | -64 | 3 |
| 12/31/2024 | 0 | -141 | -130 | -127 | 3 |
| 12/31/2023 | 0 | -117 | -125 | -101 | 2 |
| 3/31/2023 | 0 | -87 | -89 | -89 | N/A |
| 12/31/2022 | 0 | -76 | -77 | -77 | N/A |
| 9/30/2022 | 0 | -73 | -68 | -68 | N/A |
| 6/30/2022 | 0 | -71 | -64 | -64 | N/A |
| 3/31/2022 | 0 | -70 | -60 | -60 | N/A |
| 12/31/2021 | 0 | -71 | -61 | -61 | N/A |
| 9/30/2021 | 0 | -64 | -49 | -49 | N/A |
| 6/30/2021 | 0 | -47 | -40 | -40 | N/A |
| 3/31/2021 | 0 | -37 | -36 | -36 | N/A |
| 12/31/2020 | 0 | -32 | -30 | -30 | N/A |
| 9/30/2020 | 0 | -34 | -30 | -30 | N/A |
| 6/30/2020 | 0 | -35 | -32 | -32 | N/A |
| 3/31/2020 | 0 | -33 | -29 | -29 | N/A |
| 12/31/2019 | 0 | -26 | -21 | -21 | N/A |
| 9/30/2019 | 0 | -18 | -14 | -14 | N/A |
| 6/30/2019 | 0 | -14 | -9 | -9 | N/A |
| 3/31/2019 | 0 | -9 | -8 | -8 | N/A |
| 12/31/2018 | 0 | -7 | -7 | -7 | N/A |
| 9/30/2018 | 0 | -6 | -7 | -7 | N/A |
| 6/30/2018 | 0 | -5 | -6 | -6 | N/A |
| 3/31/2018 | 0 | -4 | -5 | -5 | N/A |
| 12/31/2017 | 0 | -1 | -5 | -3 | N/A |
| 9/30/2017 | 0 | -1 | -4 | -3 | N/A |
| 6/30/2017 | 1 | 0 | -3 | -2 | N/A |
| 3/31/2017 | 1 | 0 | -3 | -2 | N/A |
| 12/31/2016 | 1 | -2 | N/A | -2 | N/A |
| 9/30/2016 | 3 | -1 | N/A | -2 | N/A |
| 6/30/2016 | 3 | 0 | N/A | -2 | N/A |
| 3/31/2016 | 3 | 0 | N/A | -2 | N/A |
| 12/31/2015 | 3 | 0 | N/A | -2 | N/A |
| 9/30/2015 | 2 | 0 | N/A | -2 | N/A |
| 6/30/2015 | 2 | -1 | N/A | -2 | N/A |
| 3/31/2015 | 2 | -1 | N/A | -2 | N/A |
| 12/31/2014 | 2 | -2 | N/A | -3 | N/A |
| 9/30/2014 | 2 | -2 | N/A | -3 | N/A |
| 6/30/2014 | 2 | -1 | N/A | -4 | N/A |
| 3/31/2014 | 2 | -1 | N/A | -3 | N/A |
| 12/31/2013 | 2 | -1 | N/A | -3 | N/A |
| 9/30/2013 | 2 | -1 | N/A | -3 | N/A |
| 6/30/2013 | 2 | -2 | N/A | -3 | N/A |
| 3/31/2013 | 2 | -10 | N/A | -3 | N/A |
| 12/31/2012 | 2 | -13 | N/A | -3 | N/A |
| 9/30/2012 | 3 | -15 | N/A | -2 | N/A |
| 6/30/2012 | 3 | -14 | N/A | -2 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 0A4U is forecast to remain unprofitable over the next 3 years.
Beneficios vs. Mercado: 0A4U is forecast to remain unprofitable over the next 3 years.
Beneficios de alto crecimiento: 0A4U is forecast to remain unprofitable over the next 3 years.
Ingresos vs. Mercado: 0A4U's revenue (69% per year) is forecast to grow faster than the UK market (4.5% per year).
Ingresos de alto crecimiento: 0A4U's revenue (69% per year) is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if 0A4U's Return on Equity is forecast to be high in 3 years time